ESMO scientific and educational resources on this topic
Recent medwireNews, books and resources from conferences are for ESMO Members only.
Tumour Sites: Central Nervous System Malignancies
Latest ESMO videos
Featured medwireNews
BRAF–MEK Inhibition May Offer ‘Notable Activity’ Against BRAF-Mutated Glioma
Adjuvant Temozolomide Benefit Confirmed For 1p/19q Non-Co-Deleted Anaplastic Glioma
Low Risk Of Intracranial Malignancy After Stereotactic Radiosurgery
HRQoL Data Add Support For TTFields In Glioblastoma Patients
E-Learning
ESMO E-Learning: Multidisciplinary Treatment of Glioblastoma
ESMO E-Learning: Management of Patients with Brain Metastases: Focusing on Radiotherapy
Factsheets on Biomarkers
TERT Mutations in Glioma: ESMO Biomarker Factsheet
MGMT Promoter Methylation in Glioma: ESMO Biomarker Factsheet
IDH1/2 Mutations in Glioma: ESMO Biomarker Factsheet
1p/19q Co-deletion in Glioma: ESMO Biomarker Factsheet
Meeting resources
Invited Discussant
Presenter: Anna Di Giacomo
Session: Mini Oral session 2
Resources:
Slides
Webcast
Successes, pitfalls, and failures: A clinical perspective
Presenter: Anna Di Giacomo
Session: The future of CNS tumors: Learning from failures and driven by biology
Resources:
Slides
Webcast
The immune microenvironment of primary and metastatic brain tumours
Presenter: Andrea Anichini
Session: The future of CNS tumors: Learning from failures and driven by biology
Resources:
Slides
Webcast
The integrated genomic and epigenomic landscape of brain tumours
Presenter: Monika Hegi
Session: The future of CNS tumors: Learning from failures and driven by biology
Resources:
Slides
Webcast
Future perspectives on brain tumours' treatment
Presenter: Michael Weller
Session: The future of CNS tumors: Learning from failures and driven by biology
Resources:
Slides
Webcast